NASDAQ: HLVXHillevax Inc Stock Ownership - Who owns Hillevax?
Insider buying vs selling
Have Hillevax Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert Hershberg | President and Chief Executive Officer | 2025-02-11 | 11,901 | $1.77 | $21.01kSell |
| Shane Maltbie | Chief Financial Officer | 2025-02-11 | 4,345 | $1.76 | $7.66kSell |
| Robert Hershberg | President and Chief Executive Officer | 2025-02-04 | 14,634 | $1.89 | $27.66kSell |
| Shane Maltbie | Chief Financial Officer | 2025-02-04 | 3,946 | $1.89 | $7.46kSell |
HLVX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when HLVX insiders and whales buy or sell their stock.
HLVX Shareholders
What type of owners hold Hillevax Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Frazier Life Sciences Management LP | 21.17% | 10,617,062 | $19.64M | Institution |
| Frazier Life Sciences X LP | 17.02% | 8,535,337 | $15.79M | Insider |
| Takeda Pharmaceutical Co Ltd | 13.41% | 6,724,000 | $12.44M | Insider |
| Takeda Pharmaceutical Co Ltd | 13.41% | 6,724,000 | $12.44M | Institution |
| Tang Capital Management LLC | 9.81% | 4,920,000 | $9.10M | Institution |
| Lightspeed Management Company LLC | 4.59% | 2,303,871 | $4.26M | Institution |
| Blackrock Inc | 4.18% | 2,095,512 | $3.88M | Institution |
| Franklin Resources Inc | 3.90% | 1,957,619 | $3.62M | Institution |
| Deerfield Management Company LP Series C | 3.75% | 1,882,654 | $3.48M | Institution |
| Carlyle Group Inc | 3.67% | 1,838,486 | $3.40M | Institution |
HLVX vs Biotech Stocks
Hillevax Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.